glenmark pharma

Why are pharma giants looking to spin off their API business?

Lupin has been reportedly looking to demerge its API business, Glenmark Pharma is looking to sell Glenmark Life Sciences as well. Why? Forbes India explains

ByNaini Thaker

Home

Glenmark-pharma

Subscribe Now

Latest News

Photo of the day: India says Go
ByForbes India
How to ease the pain of mass layoffs during recessions
ByStanford
Graphic of the day: Double-Digit Growth
BySamreen Wani
We want to lead the change in the fashion industry: H&M’s Helena Kuylenstierna
BySamidha Jain